Cargando…
Chronic Invasive Aspergillosis with Fulminant Mucormycosis Sparing Palate in a Post-COVID-19 Patient - A Case Report
RATIONALE: COVID-19 patients, especially immunocompromised or severely ill, have a higher probability of suffering from invasive fungal infections. PATIENT CONCERNS: A 41-years-old male reported with pain and heaviness in the face for the past 20 days. Patient had tested COVID-19 positive 20 days ba...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527835/ https://www.ncbi.nlm.nih.gov/pubmed/36199463 http://dx.doi.org/10.4103/ams.ams_296_21 |
Sumario: | RATIONALE: COVID-19 patients, especially immunocompromised or severely ill, have a higher probability of suffering from invasive fungal infections. PATIENT CONCERNS: A 41-years-old male reported with pain and heaviness in the face for the past 20 days. Patient had tested COVID-19 positive 20 days back and was recently diagnosed with diabetes mellitus. On histopathological examination numerous hyphae resembling mucor and asper fungi were evident. DIAGNOSIS: Chronic invasive aspergillosis with fulminant mucormycosis sparing palate. TREATMENT: Since the lesion was spreading very rapidly the patient was referred to an isolation facility for further management. OUTCOMES: We have postulated few hypothesis for the coinfection of aspergillosis and mucormycosis in our patient. TAKE-AWAY LESSONS: It is important for the clinicians to systematically screen post COVID-19 patients for fungal infections, especially in immunocompromised and severely ill patients. |
---|